MP-301

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameMP-301
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitochondrial proteins modulatorsBrain-derived neurotrophic factor expression modulators
TargetsMitochondrial proteinsBrain-derived neurotrophic factor
Therapy Area/IndicationsObesityDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMitochon Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitochon Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsObesityDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A